Bicycle Therapeutics BCYC
NASDAQ BCYC
$3.56 -0.12 (-3.26%)
At close: Oct 1, 2026 · 4:00 PM EDT

Bicycle Therapeutics (BCYC) Liabilities and Shareholders Equity (2018 - 2026)

Updated

Bicycle Therapeutics (BCYC) recorded Liabilities and Shareholders Equity of $606.58 million in Q2 2026, down 27.1% from $832.18 million a year earlier and down 7.0% from the prior quarter.

Analysis

Bicycle Therapeutics (BCYC) Liabilities and Shareholders Equity (2018 - 2026) Analysis & Trends

At the end of FY2025, Bicycle Therapeutics reported Liabilities and Shareholders Equity of $717.6 million, down 25.0% from FY2024.

  • Annual Liabilities and Shareholders Equity has a five-year compound annual growth rate of 34.8% (FY2020 to FY2025).
  • Across earlier years, Liabilities and Shareholders Equity came in at $956.87 million in FY2024 (+60.7%), $595.34 million in FY2023 (+45.0%), $410.61 million in FY2022 (-14.4%) and $479.79 million in FY2021 (+197.7%).
  • The Q2 2026 figure is the lowest quarterly Liabilities and Shareholders Equity since Q1 2024.
  • On a year-over-year basis, Liabilities and Shareholders Equity has declined for five consecutive quarters, with growth averaging 6.9% over the last eight quarters.
  • Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 197.7% in Q4 2021, against a decline of 27.1% in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $652.4 million (Q1 2026), $717.6 million (Q4 2025) and $763.95 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Bicycle Therapeutics 256.92 Mn 256.92 Mn - 606.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 606.58 Mn
Mar 31, 2026 652.40 Mn
Dec 31, 2025 717.60 Mn
Sep 30, 2025 763.95 Mn
Jun 30, 2025 832.18 Mn
Mar 31, 2025 883.89 Mn
Dec 31, 2024 956.87 Mn
Sep 30, 2024 996.75 Mn
Jun 30, 2024 1.06 Bn
Mar 31, 2024 547.14 Mn
Dec 31, 2023 595.34 Mn
Sep 30, 2023 638.68 Mn
Jun 30, 2023 454.17 Mn
Mar 31, 2023 428.80 Mn
Dec 31, 2022 410.61 Mn
Sep 30, 2022 417.15 Mn
Jun 30, 2022 445.48 Mn
Mar 31, 2022 459.56 Mn
Dec 31, 2021 479.79 Mn
Sep 30, 2021 281.33 Mn
API Access

Bicycle Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=BCYC&period=max&api_key=YOUR_API_KEY